About Sanyal biotechnology

About company

Sanyal Biotechnology is a contract research organization that specializes in pre-clinical small animal model screening of drugs. The biotech was built to serve the needs of clients who seek a more physiologically relevant small animal model for their preclinical research into liver disease and other comorbidities resulting from the metabolic syndrome. It has developed a proprietary isogenic mouse model, the DIAMONDᵀᴹ mouse, that develops NAFLD and NASH solely as a result of Western Diet. The progression of the pathology and physiological changes exactly parallel development of human liver disease due to metabolic syndrome.